Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders

Haematologia

Volumn 31, Issue 1, 2001, Pages 7-16

  Meletis, J ^a   Terpos, E ^a   Samarkos, M ^a   Meletis, C ^a   Konstantopoulos, K ^a   Komninaka, V ^a   Apostolidou, E ^a   Benopoulou, O ^a   Korovesis, K ^a   Mavrogianni, D ^a   Variami, E ^a   Yataganas, X ^a   Loukopoulos, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; ERYTHROCYTE ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL;

ANTIGEN DETECTION; APLASTIC ANEMIA; ARTICLE; BLOOD DONOR; BLOOD GROUP TYPING; BONE MARROW HYPOPLASIA; CELL CLONE; CELL LEVEL; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ERYTHROCYTE; GEL; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; INFECTION; INTRAVASCULAR HEMOLYSIS; LEUKEMIA; MAJOR CLINICAL STUDY; MOLECULE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; SERODIAGNOSIS; STEM CELL; THROMBOCYTHEMIA; VEIN THROMBOSIS;

ANEMIA, APLASTIC; ANTIGENS, CD55; ANTIGENS, CD59; ERYTHROCYTE COUNT; ERYTHROCYTES; HUMANS; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS;

EID: 18044374517     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: 10.1163/15685590151092643     Document Type: Article

References (39)

1. The molecular basis of paroxysmal nocturnal hemoglobinuria
2. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria
3. The molecular basis of paroxysmal nocturnal hemoglobinuria
4. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH)
5. Phosphatydilinositol-linked proteins and Paroxysmal Nocturnal Hemoglobinuria
6. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria
7. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
8. Defective glycosyl phosphatidylinositol (GPI)-anchor synthesis and paroxysmal nocturnal hemoglobinuria
9. Specific defect in N-acetylglucosamine incorporation in the GPI anchor synthetic pathway in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria
10. Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria
11. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link
12. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia
13. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored protein
14. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes
15. Long-term follow-up of severe aplastic patients treated with antithymocyte globulin
16. Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy
17. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes
18. Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy
19. "PNH-like" red cells populations in acute leukemia and myeloproliferative syndromes
20. Paroxysmal nocturnal hemoglobinuria and the myeloproliferative syndrome
21. The PNH abnormality in myeloproliferative disorders: Association of PNH and acute erythremic myelosis in two children
22. The problem of clonality in aplastic anemia: Dr Damshek's riddle, restated
23. Paroxysmal nocturnal haemoglobinuria: Clinical manifestations, haematology and nature of disease
24. Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria
25. Diagnostic de I'hemoglobinurie nocturne paroxystique: Utilisation d' un anticorps monoclonal dirige contre la glycoproteine DAF
26. Detection of "PNH Red Cell" Populations in Hematological Disorders Using the Sephacryl Gel Test Micro Typing System
27. - erythrocytes in microtyping cards
28. Diagnostic rapide des hemoglobinuries nocturnes paroxystiques par agglutination en gel
29. Paroxysmal nocturnal hemoglobinuria: Learning about PNH cells from patients and mice
30. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment
31. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
32. Hypocellular myelodysplastic syndromes (MDS): New proposals
33. Circulating activated suppressor T lymphocytes in aplastic anemia
34. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow
35. Antithymocyte globulin for patients with myelodysplastic syndrome
36. Trisomy 8 in a patient who responded to therapy with all-trans-retinoid acid and developed paroxysmal nocturnal haemoglobinuria
37. Sequential development of myelodysplasia and paroxysmal nocturnal hemoglobinuria in a patient with preceding aplastic anemia
38. Antibody cross-linking of the glycosylphosphatidylinositol-linked protein CD59 on hematopoietic cells induces signaling pathways resembling activation by complement
39. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum